Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 04, 2025 15:13 ET | Source: NanoNewron

NanoNewron Appoints Industry Veteran Marco Taglietti, M.D., as Chief Executive Officer to Lead the Company and the Development of Their Promising Alzheimer’s Compound

Marco Taglietti, MD is appointed CEO of NanoNewron, a company developing TNF-α inhibitors for Alzheimer’s, engineered to cross the Blood-Brain Barrier
February 06, 2024 09:00 ET | Source: INmune Bio, Inc.

INmune Bio to Participate in Baird’s Biotech Discovery Series Webcast on February 13, 2024

Boca Raton, Florida, Feb. 06, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company targeting microglial activation and neuroinflammation as...
August 23, 2021 15:52 ET | Source: Sorrento Therapeutics, Inc.

Sorrento Publishes Positive Initial Results of SOFUSA® Lymphatic Drug Delivery System in a Phase 1b Rheumatoid Arthritis Study Using Enbrel

Rheumatoid Arthritis (RA) is one of many chronic autoimmune conditions affecting over 20 million people in the United States (NIH, 2017).Sofusa is a revolutionary technology which delivers biologic...
June 11, 2021 09:38 ET | Source: The Insight Partners

GMP Cytokines Market to Outstrip $158.13 Million by 2027 Growing Sturdy at 8.1% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com

Pune, India., June 11, 2021 (GLOBE NEWSWIRE) -- GMP Cytokines Market: Key InsightsAccording to our new research study on “GMP Cytokines Market to 2027 – Global Analysis and Forecast – by Type,...
November 18, 2020 09:00 ET | Source: Enosi Life Sciences

Enosi Life Sciences Files Patent for TNF-Inhibiting Molecules EN1001, EN2001 and EN3001

SAN DIEGO, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Enosi Life Sciences Corp. (“Enosi” or the “Company”), a drug research and development company focused on providing industry-leading therapeutics for...
September 02, 2020 09:00 ET | Source: Enosi Life Sciences

Therapeutic Antibody Pioneers Professor Sir Marc Feldmann and Dr. H. Michael Shepard Formally Launch Enosi Life Sciences

SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- World-renowned scientists Professor Sir Marc Feldmann and Dr. H. Michael Shepard are pleased to announce the formal launch of Enosi Life Sciences...